In the course of screening for synthetic lethal interactions, researchers have identified a new mechanism for the formation of DNA lesions that trap the enzyme poly(ADP-ribose) polymerase (PARP) as well as dozens of previously unknown genetic changes that could sensitize cells to PARP inhibition.